NEWS | BEAM Alliance

NEWS

Gedea Biotech has received 1 MSEK for clinical study for CE mark of new product

Gedea Biotech has received 1 MSEK for clinical study for CE mark of new product

Smile Company Gedea Biotech has received 1 MSEK  in Vinnova funding in Swelife and MedTech4Health’s joint announcement “Project for better health”. The money will finance the first clinical trial in patients with vaginal fungal infection.

Full PR available here